Dimensional Fund Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,457,976
Closed -$9.83M 3423
2019
Q4
$9.83M Buy
2,457,976
+181,788
+8% +$854K ﹤0.01% 2357
2019
Q3
$11.2M Buy
2,276,188
+38,881
+2% +$218K ﹤0.01% 2302
2019
Q2
$13.6M Sell
2,237,307
-17,167
-0.8% -$91.2K 0.01% 2260
2019
Q1
$13.1M Buy
2,254,474
+126,116
+6% +$1.3M 0.01% 2284
2018
Q4
$28.6M Buy
2,128,358
+395,246
+23% +$6.66M 0.01% 1764
2018
Q3
$33.6M Buy
1,733,112
+513,969
+42% +$10.9M 0.01% 1813
2018
Q2
$31.2M Sell
1,219,143
-77,314
-6% -$1.8M 0.01% 1847
2018
Q1
$26.1M Sell
1,296,457
-16,624
-1% -$388K 0.01% 1901
2017
Q4
$26.4M Buy
1,313,081
+418,412
+47% +$8.23M 0.01% 1907
2017
Q3
$18.5M Buy
894,669
+536,412
+150% +$9.07M 0.01% 2095
2017
Q2
$5.3M Buy
358,257
+54,661
+18% +$911K ﹤0.01% 2561
2017
Q1
$4.84M Sell
303,596
-100
-0% -$1.44K ﹤0.01% 2582
2016
Q4
$3.83M Buy
303,696
+11,902
+4% +$222K ﹤0.01% 2623
2016
Q3
$8.17M Buy
291,794
+255,006
+693% +$8.56M ﹤0.01% 2329
2016
Q2
$1.29M Buy
+36,788
New +$1.16M ﹤0.01% 2870

Other funds holding DPLO

Dimensional Fund Advisors's DPLO Position: Q1 2020 in Review

Dimensional Fund Advisors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 2,457,976 shares — an estimated $9.83M sold.

Dimensional Fund Advisors first reported a position in DPLO in Q2 2016 and held it in 15 quarters. The position peaked at $33.6M in Q3 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

  • Dimensional Fund Advisors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
  • Dimensional Fund Advisors sold 2,457,976 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $9.83M.
  • Dimensional Fund Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2016 and held it in 15 quarters.
  • Dimensional Fund Advisors's DIPLOMAT PHARMACY, INC. position peaked at $33.6M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Dimensional Fund Advisors's 13F filing for Q1 2020, filed 14 May 2020.